Clinical trial PROSPERITY
A Prospective non-interventional study (NIS) of trastuzumab deRuxtecan (T-DXd) for adult patients with advanced HER2-pOsitive gaStric or gastroesoPhageal junction (GEJ) adEnocarcinoma who have Received a prIor Trastuzumab-based regimen, accompanied by a disease registrY of patients treated with conventional therapies in a real-world setting in Europe (PROSPERITY) (DS8201-0007-NIS-MA)
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial open for recruitment |
| Trial type |
Prospective observational study
|
| Academic trial | Non |
| Sponsor | Daiichi Sankyo |
| BECT Identifier | B6702024000342 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05993234 |
| Last update |